ERS Short Guideline: Inhaled corticosteroid withdrawal in COPD

M. Miravitlles (Barcelona (CT), Spain)

Source: Virtual Congress 2020 – Airway diseases
Session: Airway diseases
Session type: State of the art session
Number: 4515
Disease area: Airway diseases

WebcastSlide presentation

Rating: 4
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Miravitlles (Barcelona (CT), Spain). ERS Short Guideline: Inhaled corticosteroid withdrawal in COPD. Virtual Congress 2020 – Airway diseases

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Withdrawal of inhaled corticosteroids in COPD: a European Respiratory Society guideline
Source: Guideline 2020
Year: 2020



Withdrawal of inhaled corticosteroids in COPD: a European Respiratory Society guideline
Source: Eur Respir J, 55 (6) 2000351; 10.1183/13993003.00351-2020
Year: 2020



Microbiome Use to Stratify Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (MUSIC) trial: baseline data and impact of inhaled corticosteroid withdrawal in severe COPD with frequent exacerbations
Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils
Year: 2020


The effect of Corticophobia on Inhaled Corticosteroid Treatment Compliance In Adults with Asthma
Source: International Congress 2018 – Asthma analysis
Year: 2018


Tiotropium as add-on therapy to inhaled corticosteroids for patients with symptomatic asthma: Lung function and safety
Source: Annual Congress 2013 –LAMA, LABA, ICS and their combinations for the treatment of asthma and COPD
Year: 2013


ERS guideline on withdrawal of inhaled corticosteroids in COPD
Source: ERS webinar 2021: ERS guideline on withdrawal of inhaled corticosteroids in COPD
Year: 2021


Long-acting beta2 agonist without concomitant inhaled corticosteroids in children with asthma in primary care
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014


Adherence with inhaled corticosteroids in asthma: Does pregnancy lead to improved adherence?
Source: International Congress 2014 – Asthma: still a heterogeneous condition!
Year: 2014

Late Breaking Abstract - Impact of maintenance and reliever therapy (MART)-focused asthma guideline on SABA prescriptions
Source: Virtual Congress 2021 – Highlights for primary care in 2021
Year: 2021



Inhaled corticosteroids in COPD: the case against
Source: Eur Respir J 2009; 34: 13-16
Year: 2009


The impact of stepwise withdrawal of inhaled corticosteroids on exacerbations in COPD patients receiving dual bronchodilation: WISDOM study
Source: International Congress 2014 – Bronchodilators for asthma and COPD
Year: 2014



Efficacy and safety of indacaterol acetate on ICS background therapy in asthma
Source: International Congress 2014 – Asthma and COPD management
Year: 2014


Inhaled corticosteroids: a controversial add-on treatment in COPD
Source: Eur Respir J 2010; 36: 973-974
Year: 2010


Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids
Source: International Congress 2016 – New findings in mucosal immunology
Year: 2016


Tiotropium as add-on to inhaled corticosteroids significantly improves asthma control as reflected by the ACQ responder rate
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013


Bronchodilator responsiveness after ICS treatment
Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma
Year: 2016


Evaluation of Asthma control and oral corticosteroids in Severe Asthma
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021

The impact of stepwise withdrawal of inhaled corticosteroids on lung function in COPD patients receiving dual bronchodilation: WISDOM study
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014


Late Breaking Abstract - Management of asthma in pregnancy using fractional exhaled nitric oxide (FENO) to adjust inhaled corticosteroid (ICS) dose did not improve perinatal outcomes: the Breathing for Life Trial (BLT)
Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers
Year: 2020


Effect of inhaled steroid therapy on treatment response in hosptalized pneumonia patients: Results from Turkish Thoracic Society database
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015